Repligen Corporation to Present at William Blair Growth Conference
Repligen Corporation (NASDAQ:RGEN), a leading bioprocessing technology company, has announced its participation in the William Blair 45th Annual Growth Stock Conference. The event is scheduled for June 3-5 in Chicago. Olivier Loeillot, President and CEO, will deliver a company overview presentation on June 3rd at 1:20 p.m. CT. Investors can access the live webcast through Repligen's Investor Relations website, with a replay available for a limited time after the event.
Repligen Corporation (NASDAQ:RGEN), un'azienda leader nella tecnologia di bioprocessing, ha annunciato la sua partecipazione al William Blair 45th Annual Growth Stock Conference. L'evento si terr脿 dal 3 al 5 giugno a Chicago. Olivier Loeillot, Presidente e CEO, presenter脿 una panoramica dell'azienda il 3 giugno alle 13:20 CT. Gli investitori potranno seguire la diretta streaming tramite il sito web delle Relazioni con gli Investitori di Repligen, con la possibilit脿 di rivedere la registrazione per un periodo limitato dopo l'evento.
Repligen Corporation (NASDAQ:RGEN), una empresa l铆der en tecnolog铆a de bioprocesos, ha anunciado su participaci贸n en la William Blair 45th Annual Growth Stock Conference. El evento se llevar谩 a cabo del 3 al 5 de junio en Chicago. Olivier Loeillot, Presidente y CEO, ofrecer谩 una presentaci贸n general de la empresa el 3 de junio a la 1:20 p.m. CT. Los inversores podr谩n acceder a la transmisi贸n en vivo a trav茅s del sitio web de Relaciones con Inversores de Repligen, con una repetici贸n disponible por tiempo limitado despu茅s del evento.
Repligen Corporation (NASDAQ:RGEN)鞚� 靹犽弰鞝侅澑 氚旍澊鞓ろ攧搿滌劯鞁� 旮办垹 須岇偓搿滌劀 William Blair 45th Annual Growth Stock Conference鞐� 彀戈皜頃� 瓴冹澊霛缄碃 氚滍憸頄堨姷雼堧嫟. 頄夓偓電� 6鞗� 3鞚茧秬韯� 5鞚缄箤歆� 鞁滌勾瓿犾棎靹� 鞐措雼堧嫟. Olivier Loeillot 靷灔 瓴� CEO臧� 6鞗� 3鞚� 鞓ろ泟 1鞁� 20攵�(欷戨秬 響滌鞁�)鞐� 須岇偓 臧滌殧 頂勲爤鞝犿厡鞚挫厴鞚� 歆勴枆頃� 鞓堨爼鞛呺媹雼�. 韴瀽鞛愲摛鞚� Repligen鞚� 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼毳� 韱淀暣 靸濎瓿勳棎 鞝戩啀頃� 靾� 鞛堨溂氅�, 頄夓偓 頉� 鞚检爼 旮瓣皠 霃欖晥 雼れ嫓氤搓赴 靹滊箘鞀る弰 鞝滉车霅╇媹雼�.
Repligen Corporation (NASDAQ:RGEN), une entreprise leader dans la technologie des bioproc茅d茅s, a annonc茅 sa participation 脿 la William Blair 45th Annual Growth Stock Conference. L'茅v茅nement est pr茅vu du 3 au 5 juin 脿 Chicago. Olivier Loeillot, Pr茅sident et CEO, pr茅sentera un aper莽u de l'entreprise le 3 juin 脿 13h20 CT. Les investisseurs pourront acc茅der 脿 la diffusion en direct via le site des Relations Investisseurs de Repligen, avec un replay disponible pour une dur茅e limit茅e apr猫s l'茅v茅nement.
Repligen Corporation (NASDAQ:RGEN), ein f眉hrendes Unternehmen im Bereich Bioprozess-Technologie, hat seine Teilnahme an der William Blair 45th Annual Growth Stock Conference angek眉ndigt. Die Veranstaltung findet vom 3. bis 5. Juni in Chicago statt. Olivier Loeillot, Pr盲sident und CEO, wird am 3. Juni um 13:20 Uhr CT eine Unternehmens眉bersicht pr盲sentieren. Investoren k枚nnen den Live-Webcast 眉ber die Investor-Relations-Website von Repligen verfolgen, mit einer zeitlich begrenzten Wiederholung nach der Veranstaltung.
- None.
- None.
WALTHAM, Mass., May 22, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be participating at the William Blair 45th Annual Growth Stock Conference being held June 3 鈥� 5 in Chicago. Olivier Loeillot, President and Chief Executive Officer is scheduled to present a company overview on June 3rd at 1:20 p.m. CT.
A live webcast of the conference presentation will be accessible through Repligen鈥檚聽 website at , and will be available for replay for a limited period of time following the event.
About Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. We are 鈥渋nspiring advances in bioprocessing鈥� for the customers we serve; primarily biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Our focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Our corporate headquarters are located in Waltham, Massachusetts, and the majority of our manufacturing sites are in the U.S., with additional key sites in Estonia, France, Germany, Ireland, the Netherlands and Sweden. For more information about the company see our website at , and follow us on .
Repligen Contact:
Jacob Johnson
VP, Investor Relations
(781) 419-0204
[email protected]
FAQ
When is Repligen (RGEN) presenting at the William Blair Growth Conference 2025?
Who will present for Repligen (RGEN) at the William Blair Conference?
How can investors watch Repligen's (RGEN) presentation at the William Blair Conference?
What is the duration of the William Blair Growth Conference 2025?
